ADVERTISEMENT

Richter and Forest Laboratories extend cooperation

Pharma

Hungarian drug maker Richter Gedeon Rt and its wholly owned subsidiary Richter USA, and Forest Laboratories Holdings, a wholly owned subsidiary of Forest Laboratories, Inc., have entered into two new cooperation agreements involving two novel mechanisms targeted for the treatment of various CNS conditions, Richter announced. The two new agreements build upon the existing collaboration between the companies announced last year for a novel antipsychotic. The first new collaboration will focus upon a group of compounds that will be developed for the treatment of chronic pain and other CNS conditions. Under the first agreement, Forest will pay Richter undisclosed upfront and milestone payments in addition to royalties and will have exclusive rights in the U.S. and Canada. The two companies will jointly fund the development program.
Under the second agreement, Forest will pay Richter undisclosed upfront and milestone payments in addition to royalties and will have exclusive rights in North America while Richter will retain exclusive rights in Europe and countries of the former Soviet Union. The two companies will share rights in all other territories. The two new agreements build upon the ongoing and successful collaboration between the two companies announced last year for the novel antipsychotic, Richter said.
The announcement noted that the neuropathic pain market in the United States is estimated to exceed $2 bln annually.
Hungary Motor Fuel Prices Below Regional Average Energy Trade

Hungary Motor Fuel Prices Below Regional Average

EC Advances Infringement Procedure Over Hungary's Sovereignt... EU

EC Advances Infringement Procedure Over Hungary's Sovereignt...

Hell Energy Inaugurates HUF 80 bln Capacity Expansion Manufacturing

Hell Energy Inaugurates HUF 80 bln Capacity Expansion

Puskás Arena to Host 2026 Champions League Final In Budapest

Puskás Arena to Host 2026 Champions League Final

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.